cadila healthcare (citi) Solid Quarter

Docetaxel supplies drive strong 4Q; Growth continues; Flat EBIDTA margin but lower depreciation props PAT
Date Rating Target Price Recommendation Price Broker house
8 May 2011 sell 760 (From 700) 875 citi Report

No comments:

Post a Comment